Cyclic nucleotide phosphodiesterases in the human lung
Authors:
- 1 May 1994
- journal article
- review article
- Published by Springer Nature in Lung
- Vol. 172 (3) , 129-146
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- The effect of zardaverine, an inhibitor of phosphodiesterase isoenzymes III and IV, on endotoxin‐induced airway changes in ratsClinical & Experimental Allergy, 1993
- The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-α production by human mononuclear cellsInternational Journal of Immunopharmacology, 1993
- Prospects for selective cyclic nucleotide phosphodiesterase inhibitors in the treatment of bronchial asthmaClinical & Experimental Allergy, 1992
- Phosphodiesterase inhibitors: new opportunities for the treatment of asthma.Thorax, 1991
- Effects of selective phosphodiesterase inhibitors on isolated coronary, lung and renal arteries from man and ratActa Physiologica Scandinavica, 1991
- Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitorsTrends in Pharmacological Sciences, 1990
- Phosphodiesterase Inhibition by Ro 20-1724 Reduces Hyper-IgE Synthesis by Atopic Dermatitis Cells In VitroJournal of Investigative Dermatology, 1985
- Purification and characterization of a human platelet cyclic nucleotide phosphodiesteraseBiochemistry, 1984
- INHIBITION OF HUMAN PULMONARY PHOSPHODIESTERASE ACTIVITY BY THERAPEUTIC LEVELS OF THEOPHYLLINEClinical and Experimental Pharmacology and Physiology, 1978
- Partial purification and characterization of adenosine- and guanosine-3',5'-monophosphate phosphodiesterases from human lung tissueBiochemistry, 1976